Working… Menu

A Study of Melphalan Flufenamide (Melflufen) in Combination With Dexamethasone in Relapsed Refractory Multiple Myeloma Patients (HORIZON)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02963493
Recruitment Status : Active, not recruiting
First Posted : November 15, 2016
Last Update Posted : September 2, 2021
Precision For Medicine
Information provided by (Responsible Party):
Oncopeptides AB

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : October 22, 2020
Estimated Study Completion Date : September 2022
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 October 4, 2021